Goldman Sachs’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,300
Closed -$131K 6619
2017
Q4
$131K Sell
3,300
-500
-13% -$20.8K ﹤0.01% 5643
2017
Q3
$165K Sell
3,800
-7,300
-66% -$333K ﹤0.01% 5869
2017
Q2
$531K Buy
11,100
+4,200
+61% +$196K ﹤0.01% 5048
2017
Q1
$283K Buy
6,900
+4,500
+188% +$188K ﹤0.01% 5502
2016
Q4
$92K Sell
2,400
-4,800
-67% -$195K ﹤0.01% 6179
2016
Q3
$387K Sell
7,200
-2,800
-28% -$130K ﹤0.01% 5277
2016
Q2
$430K Buy
10,000
+5,400
+117% +$227K ﹤0.01% 4993
2016
Q1
$232K Sell
4,600
-2,800
-38% -$135K ﹤0.01% 5490
2015
Q4
$468K Sell
7,400
-8,900
-55% -$606K ﹤0.01% 4984
2015
Q3
$1.07M Sell
16,300
-2,000
-11% -$133K ﹤0.01% 4411
2015
Q2
$1.24M Buy
18,300
+5,100
+39% +$281K ﹤0.01% 4331
2015
Q1
$564K Sell
13,200
-3,800
-22% -$169K ﹤0.01% 5007
2014
Q4
$840K Buy
17,000
+1,300
+8% +$52K ﹤0.01% 4763
2014
Q3
$451K Sell
15,700
-31,500
-67% -$855K ﹤0.01% 5372
2014
Q2
$1.24M Buy
47,200
+39,400
+505% +$1.02M ﹤0.01% 4499
2014
Q1
$434K Sell
7,800
-16,100
-67% -$926K ﹤0.01% 5406
2013
Q4
$1.15M Buy
23,900
+6,000
+34% +$252K ﹤0.01% 4614
2013
Q3
$752K Buy
17,900
+16,300
+1,019% +$776K ﹤0.01% 4815
2013
Q2
$72K Buy
+1,600
New +$62.7K ﹤0.01% 5964

Goldman Sachs's IMPV Position: Q1 2019 in Review

Goldman Sachs sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 1,602,636 shares — an estimated $89.3M sold.

Goldman Sachs first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $89.3M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Goldman Sachs reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Goldman Sachs sold 1,602,636 Imperva, Inc. shares in Q1 2019, an estimated $89.3M.
  • Goldman Sachs first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Goldman Sachs's Imperva, Inc. position peaked at $89.3M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.